Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphatidylinositol 3-Kinase | 3 | 2023 | 130 | 1.460 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 138 | 0.820 |
Why?
|
| Immune Evasion | 1 | 2023 | 360 | 0.700 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2023 | 1144 | 0.640 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2017 | 2842 | 0.590 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 721 | 0.490 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2021 | 2938 | 0.460 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2012 | 13 | 0.450 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 625 | 0.360 |
Why?
|
| Neoplasms | 6 | 2022 | 21596 | 0.340 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2723 | 0.330 |
Why?
|
| Immunotherapy | 2 | 2023 | 4414 | 0.320 |
Why?
|
| Retinoblastoma Protein | 3 | 2015 | 701 | 0.290 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1525 | 0.260 |
Why?
|
| Transcription Factors | 6 | 2017 | 12164 | 0.250 |
Why?
|
| Neoplasm Metastasis | 3 | 2017 | 4839 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 3 | 2015 | 380 | 0.230 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2018 | 890 | 0.230 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2021 | 17 | 0.210 |
Why?
|
| Armadillo Domain Proteins | 1 | 2021 | 22 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2023 | 520 | 0.180 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2018 | 2948 | 0.160 |
Why?
|
| Muscle Stretching Exercises | 1 | 2018 | 33 | 0.160 |
Why?
|
| Cell Cycle | 4 | 2022 | 2964 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2020 | 349 | 0.150 |
Why?
|
| Nerve Degeneration | 1 | 2021 | 748 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2018 | 1727 | 0.140 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2021 | 700 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 1363 | 0.140 |
Why?
|
| DNA Damage | 2 | 2016 | 2423 | 0.130 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2016 | 194 | 0.130 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2014 | 2014 | 0.130 |
Why?
|
| Signal Transduction | 6 | 2023 | 23387 | 0.130 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2015 | 105 | 0.120 |
Why?
|
| Kangai-1 Protein | 1 | 2014 | 25 | 0.120 |
Why?
|
| Cell Movement | 3 | 2017 | 5212 | 0.120 |
Why?
|
| Paclitaxel | 1 | 2021 | 1707 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 577 | 0.120 |
Why?
|
| Myoblasts | 1 | 2015 | 238 | 0.120 |
Why?
|
| Axons | 1 | 2021 | 1681 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 709 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2015 | 229 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 244 | 0.110 |
Why?
|
| Mice | 11 | 2023 | 81045 | 0.100 |
Why?
|
| Breast Neoplasms | 6 | 2022 | 20774 | 0.100 |
Why?
|
| Cell Line, Tumor | 7 | 2017 | 16665 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1575 | 0.100 |
Why?
|
| Tumor Microenvironment | 2 | 2020 | 3564 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 987 | 0.090 |
Why?
|
| Thiazoles | 1 | 2018 | 1484 | 0.090 |
Why?
|
| Metformin | 1 | 2017 | 829 | 0.090 |
Why?
|
| Protein Stability | 3 | 2017 | 556 | 0.090 |
Why?
|
| Up-Regulation | 3 | 2016 | 4211 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2021 | 5163 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 692 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1205 | 0.080 |
Why?
|
| HEK293 Cells | 4 | 2021 | 4200 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2016 | 11470 | 0.080 |
Why?
|
| Calcium | 1 | 2021 | 5753 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2016 | 1782 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2014 | 3612 | 0.080 |
Why?
|
| Indoleacetic Acids | 1 | 2007 | 44 | 0.080 |
Why?
|
| Animals | 12 | 2023 | 168561 | 0.080 |
Why?
|
| Acrylates | 1 | 2007 | 89 | 0.080 |
Why?
|
| Alleles | 1 | 2018 | 6931 | 0.070 |
Why?
|
| Chromatin | 1 | 2018 | 2917 | 0.070 |
Why?
|
| Sirolimus | 1 | 2013 | 1562 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 2915 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 5522 | 0.070 |
Why?
|
| Piperazines | 1 | 2015 | 2488 | 0.060 |
Why?
|
| Arabidopsis | 1 | 2007 | 459 | 0.060 |
Why?
|
| Humans | 20 | 2022 | 742088 | 0.060 |
Why?
|
| Apoptosis | 2 | 2016 | 9715 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4553 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2010 | 2500 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4029 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2010 | 2924 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 5851 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13655 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2022 | 322 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2022 | 535 | 0.040 |
Why?
|
| Doxorubicin | 2 | 2016 | 2215 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2016 | 3001 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2022 | 10472 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 12071 | 0.040 |
Why?
|
| Calcium Channels | 1 | 2021 | 621 | 0.040 |
Why?
|
| Mutation | 2 | 2018 | 29717 | 0.030 |
Why?
|
| Deoxyglucose | 1 | 2017 | 337 | 0.030 |
Why?
|
| Pseudopodia | 1 | 2016 | 172 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2022 | 1145 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2016 | 8436 | 0.030 |
Why?
|
| Genes, ras | 1 | 2017 | 691 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3444 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 608 | 0.030 |
Why?
|
| Protein Binding | 2 | 2016 | 9387 | 0.030 |
Why?
|
| Muscle Development | 1 | 2015 | 271 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 905 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2014 | 430 | 0.030 |
Why?
|
| Female | 7 | 2022 | 379592 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 875 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8425 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2016 | 1185 | 0.020 |
Why?
|
| Acetylation | 1 | 2014 | 1085 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 8300 | 0.020 |
Why?
|
| Disease Progression | 2 | 2018 | 13256 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1727 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2016 | 3127 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2015 | 849 | 0.020 |
Why?
|
| Sp1 Transcription Factor | 1 | 2010 | 144 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1509 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2010 | 275 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4438 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15994 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3689 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 5892 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 3847 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2890 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1515 | 0.020 |
Why?
|
| Receptor, erbB-2 | 1 | 2017 | 2410 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5872 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6483 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 682 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6382 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2015 | 1860 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9735 | 0.020 |
Why?
|
| Rats | 1 | 2021 | 24265 | 0.020 |
Why?
|
| Base Sequence | 1 | 2016 | 12797 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2015 | 5975 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 2107 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 21821 | 0.010 |
Why?
|
| Cytokines | 1 | 2018 | 7317 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7721 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2007 | 3133 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11363 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6115 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18006 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5867 | 0.010 |
Why?
|
| Models, Biological | 1 | 2014 | 9581 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16331 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 13029 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 11039 | 0.010 |
Why?
|
| Male | 1 | 2016 | 349538 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_